Key facts
- This page summarizes PALMISANO ROBERT J's Form 4 filing for AEON Biopharma, Inc. (AEON).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 04 Sep 2024, 21:49.
PALMISANO ROBERT J - 31 Aug 2024 Form 4 Insider Report for AEON Biopharma, Inc. (AEON)
- Reporting relationship
- Director
- Issuer ticker
- AEON
- Reported as of
- 31 Aug 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 04 Sep 2024, 21:49:34 UTC
- Prior SEC filing
- 10 Jun 2024
- Next SEC filing
- 23 May 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Alexander Wilson as attorney-in-fact for Robert J. Palmisano
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
PALMISANO ROBERT J filed Form 4 for AEON Biopharma, Inc. (AEON) on 04 Sep 2024.
Change
- Previous filing in this sequence was filed on 10 Jun 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
This filing has been restated.
Open the amended filing.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
AEON
transaction
Class A Common Stock
Award
- Transaction value
- $0
- Shares
- +36,021
- Change %
- Price
- $0.000000
- Shares after
- 36,021
- Date
- 31 Aug 2024
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
AEON
transaction
Derivative
Stock Option
Award
- Transaction value
- $0
- Shares
- +96,210
- Change %
- Price
- $0.000000
- Shares after
- 96,210
- Date
- 31 Aug 2024
- Ownership
- Direct
- Underlying class
- Class A Common Stock
- Underlying amount
- 96,210
- Exercise price
- $0.8300
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Represents an award of restricted stock units granted on August 31, 2024 (the "Grant Date"), which vests in full on the second anniversary of the Grant Date, subject to the reporting person's continued service through the applicable vesting date.
Footnote F2
Represents an award of stock options granted on August 31, 2024 (the "Grant Date"), which vest and become exercisable in substantially equal monthly installments over the eighteen months following the Grant Date, subject to the reporting person's continued service through the applicable vesting date.